ZUR STEIGERUNG DER ANTITUMORIMMUNITÄT WIRKSAMES PROTEOGLYKAN (G009)

A proteoglycan(G 009) obtained from cultured ganoderma lucidum, which contains beta -glucose, alpha -glucose, galactose, alpha -mannose and fructose as the saccharide components and glycine, lysine, alanine, histidine, arginine, valine, aspartic acid, threonine, isoleucine, serine, leucine, glutamic...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LEE, CHOON, WOO, CHUNG, HOON, CHUNG, CHUN, HEE, LEE, KWON, HAENG
Format:	Patent
Sprache:	ger
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A proteoglycan(G 009) obtained from cultured ganoderma lucidum, which contains beta -glucose, alpha -glucose, galactose, alpha -mannose and fructose as the saccharide components and glycine, lysine, alanine, histidine, arginine, valine, aspartic acid, threonine, isoleucine, serine, leucine, glutamic acid, tyrosine, proline, phenylalanine and methionine as the protein components, and has an effect of enhancing antitumor immunity.